MDxHealth (MDXH) Net Cash Flow (2021 - 2026)

MDxHealth (MDXH) has 6 years of Net Cash Flow data on file, last reported at $22.9 million in Q1 2026.

• Quarterly Net Cash Flow rose 35.52% year-over-year to $22.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$14.7 million (down 174.52% YoY) and the FY2025 annual result came in at -$17.8 million, down 197.55% from the prior year.
• Net Cash Flow advanced to $22.9 million in Q1 2026 per MDXH's latest filing, from -$21.4 million in the prior quarter.
• The five-year high for Net Cash Flow was $27.4 million in Q3 2024, with the low at -$21.4 million in Q3 2025.
• Average Net Cash Flow over 5 years is -$2.1 million, with a median of -$8.2 million recorded in 2023.
• Year-over-year, Net Cash Flow surged 175.76% in 2024 and sank 177.89% in 2025.
• MDxHealth's Net Cash Flow stood at -$10.4 million in 2022, then gained by 25.56% to -$7.7 million in 2023, then jumped by 48.95% to -$4.0 million in 2024, then sank by 440.83% to -$21.4 million in 2025, then soared by 207.2% to $22.9 million in 2026.
• Business Quant data shows MDXH's Net Cash Flow at $22.9 million in Q1 2026, -$21.4 million in Q3 2025, and -$16.3 million in Q2 2025.